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Abstract 
Obesity is a widespread chronic inflammatory disorder characterized by an increased overall 
disease burden and significant association with periodontitis. The aim of this prospective 
clinical cohort study was to investigate the effect of obesity on orthodontic tooth movement. 
Fifty-five patients (27 males, 28 females) mean age 15.1 (SD, 1.7) years and mean body mass 
index 30.2 (3.5) in obese and 19.4 (2.2) kg/m2 in normal-weight groups were followed from 
start-of-treatment to completion of tooth alignment with fixed-appliances. Primary-outcome 
was time taken to complete tooth alignment, whilst secondary-outcomes included rate of tooth 
movement and change in clinical parameters (plaque/gingival indices, unstimulated whole 
mouth salivary flow rate and gingival crevicular fluid biomarkers). Data collection took place 
at baseline (start-of-treatment at appliance-placement); at 1-hour and 1-week following 
appliance-placement; and completion of alignment. Results were analyzed by descriptive 
statistics followed by generalized estimating equation regression modelling. Obese patients 
needed slightly less time to complete tooth alignment compared to normal-weight, but this was 
non-significant for both crude and adjusted analyses. However, after adjusting for confounders 
obese patients had a significantly higher rate of tooth movement compared to normal-weight 
(+0.017 mm/day; 95 CI: 0.008,0.025; P<0.001) over the period of alignment. Explorative 
analyses indicated that levels of the adipokines leptin and resistin, the inflammatory-marker 
myeloperoxidase and the cytokine receptor for nuclear factor kappa-B ligand (RANKL) were 
significantly different between obese and normal-weight patients and associated with the 
observed rates of tooth movement. This represents the first prospective data demonstrating a 
different response in obese patients compared to normal-weight during orthodontic tooth 
movement. These differences in the response of periodontal tissues to orthodontic force in the 
presence of obesity have potential short and long-term clinical implications. 
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Introduction 
Obesity levels have been rising amongst children and adults in Western societies over the last 
few decades (Ng et al. 2014). This represents a major healthcare challenge because of the 
known associations between raised body mass index (BMI) and multiple chronic diseases, 
including insulin-resistant diabetes, cardiovascular disease and cancer (Deng et al. 2016). It 
is recognized that obesity represents a state of chronic subclinical inflammation mediated 
through the presence of excess adipose tissue (Hotamisligil 2006). Adipocytes are the 
predominant cellular component of white adipose and produce a host of metabolically-active 
proteins or adipokines, which influence metabolic function and inflammatory responses (Ouchi 
et al. 2011). These include the pro-inflammatory adipokines leptin (Zhang et al. 1994) and 
resistin (Steppan et al. 2001) and the anti-inflammatory adiponectin (Scherer et al. 1995). 
Adipose tissue can influence the intensity and resolution of inflammatory responses in 
multiple tissues (Issa and Griffin 2012; Pierpont et al. 2014). Indeed, there is evidence of an 
increased risk of chronic periodontitis (Keller et al. 2015; Suvan et al. 2011) and variation in 
inflammatory and metabolic markers in obese subjects affected by periodontal disease when 
compared to normal-weight (Papageorgiou et al. 2015a). The systemic induction of 
inflammatory markers may provide a link between obesity and periodontitis, with some current 
focus on C-reactive protein (CRP) as an important potential mediator (Pradeep et al. 2012). 
Orthodontic tooth movement takes place as a direct consequence of connective tissue 
remodeling within the periodontium and alveolar bone, which occurs through a localized 
inflammatory response induced by external force (Meikle 2006). This triggers the release of 
essential biochemical mediators, which are often detectable within gingival crevicular fluid 
(GCF) (Kapoor et al. 2014). In particular, the tissue-modulating factors receptor for nuclear 
factor kappa-B ligand (RANKL), matrix metalloproteinases (MMPs) and tissue-inhibitors of 
MMPs (TIMPs) (Grant et al. 2013). Obesity is also known to influence systemic bone 
metabolism through complex mechanical, hormonal, and inflammatory interactions (Lopez-
Gomez et al. 2016) with associations between obesity and reduced bone remodeling (Ivaska 
et al. 2016) and increased bone mineral density (Salamat et al. 2016). Although there is little 
data relating obesity to changes in alveolar bone composition within the healthy periodontium, 
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longitudinal data has shown a significant association with increased rates of tooth eruption 
(Must et al. 2012). 
 The potential implications of adolescent obesity for orthodontic treatment have been 
highlighted (Neeley and Gonzales 2007) with increased BMI a risk factor for less cooperation 
and longer treatment duration with fixed appliances (von Bremen et al. 2016). However, 
despite know associations between raised BMI and chronic inflammatory changes within the 
periodontium, there have been no prospective investigations of orthodontic tooth movement 
in obese patients. The aim of this study was to investigate the effect of obesity on orthodontic 
tooth movement during routine treatment with fixed-appliances. Specifically, time-taken to 
complete tooth alignment and variation in clinical parameters, including GCF biomarkers. 
 
Materials and Methods 
Study design 
This prospective cohort study compared the effects of obesity on tooth alignment with fixed-
appliances. Ethical approval was obtained from the United Kingdom National Research Ethics 
Service (UK NRES) (14/LO/0769). Written-informed consent was received from all parents, 
guardians and children. We report and present data according to STROBE (von Elm et al. 
2008). 
 
Setting 
Participants fulfilling the inclusion criteria were recruited consecutively from orthodontic 
treatment clinics at King’s College London Dental Institute (Guy’s Hospital) UK between 
January 2015-January 2016. Follow-up occurred to June 2016 and covered appliance 
placement to completion of alignment. 
 
Participants 
Inclusion criteria included: (1) fixed-appliance treatment; (2) 12-18 years-old at treatment-start; 
(3) no medical contraindications or regular medication (including antibiotic-therapy) in previous 
six-months); (4) non-smokers; (5) permanent dentition; (6) mandibular arch incisor irregularity 
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index of 4-12 mm; (7) normal-weight (BMI-centile 2-91) and obese (BMI-centile >98) 
classification. Those classified as underweight (BMI-centile <2) and overweight (BMI-centile 
91-98) were excluded, respectively. 
 Subject body weight was measured to the nearest 0.1 kilogram (kg) using a calibrated 
scale and height measured to the nearest centimeter (cm) using a wall-mounted rule. BMI was 
calculated as mass (kg) divided by height in meters-squared (kg/m2). United Kingdom Royal 
College of Pediatrics and Child Health World Health Organization growth-charts were used to 
calculate and classify BMI-centile in relation to age and sex. All measurements were taken by 
a single-trained operator (HFS) using the same equipment. 
 
Variables 
Tooth alignment was calculated from scanned (3Shape R700, Copenhagen, Denmark) stone 
dental casts using an irregularity-index (Little 1975). 
Unstimulated whole mouth salivary flow rate (uWMS) was calculated as millilitre (mL) 
per minute from saliva obtained from relaxed patients spitting into a plastic tube for five-
minutes. Periodontal health was measured clinically using established-validated plaque and 
gingival indices (Loe and Silness 1963; Silness and Loe 1964). GCF was collected from the 
distal side of the lower six anterior teeth and pooled. Following isolation, teeth were gently 
dried using an air-syringe and filter-paper strips (Periopaper, OraFlow Inc. New York, USA) 
placed 1 mm into the gingival crevice for 30 seconds. If there was any contamination of the 
strip with saliva or blood it was discarded. The volume of collected fluid in the strip was 
measured directly using a Periotron 8000 electronic micro-moisture meter (OraFlow Inc. New 
York, USA) with readings converted to an actual volume by reference to the standard curve 
and flow-rate calculated (per minute). GCF was retrieved from filter strips with the addition of 
20 µl PBS and centrifugation for 5 minutes at 9200g. Samples were stored at -80 °C for 
subsequent analysis. GCF was analyzed by Luminex bead-based multiplex assay using a 
commercially available kit (R&D systems, Abingdon, UK) for detection (pg/mL) of the 
adipokines adiponectin, leptin and resistin; the inflammatory mediators myeloperoxidase 
(MPO) and CRP, and the tissue-remodeling biomarkers MMP8, MMP9, TIMP1, MMP8/TIMP1, 
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MMP9/TIMP1 and RANKL (Appendix Table 1). 
Fixed-appliances and bonding-method were standardized between groups (3M 
Victory-APC 0.022-inch brackets, MBT prescription, 3M-Unitek, Monrovia, USA). After 
bracket-bonding, a 0.014-inch nickel-titanium archwire was tied in and ligated using 
conventional elastomerics. The archwire was cut distal to the first molar teeth and not cinched. 
No bite planes, auxiliary-arches, inter-maxillary elastics, headgears or temporary anchorage 
devices were used during the investigation. All appliances were placed by postgraduate 
orthodontic trainees under direct supervision of a consultant orthodontist. 
Sample collection took place during routine appointments between the hours of 9.30 
am to 3.30 pm at baseline (start-of-treatment at appliance placement) (irregularity index, 
uWMS, plaque and gingival indices, GCF flow-rate, biomarker-analysis); 1-hour following 
appliance placement (GCF flow-rate, biomarker-analysis), 1-week following appliance 
placement (irregularity index, uWMS, plaque and gingival indices, GCF flow-rate, biomarker-
analysis); and at completion of tooth alignment (0.019 x 0.025-inch stainless-steel archwire) 
(irregularity index, uWMS, plaque and gingival indices, GCF flow-rate, biomarker-analysis). 
This was a pragmatic study undertaken in a clinical department. Patients were seen at 
approximate 6-week intervals for appliance adjustment and archwire progression took place 
as deemed clinically appropriate by treating clinicians. Patient-flow through the study is shown 
in Appendix Figure 1. 
Primary outcome was time to achieve tooth alignment in the lower arch. Secondary 
outcomes included rate of tooth movement, changes in clinical parameters and GCF 
biomarkers during treatment. There were no changes to outcomes following study 
commencement. 
 
Sample size 
Sample size was based upon previous randomized prospective data on time to completion of 
alignment with fixed-appliances, which found a mean time-to-alignment of 200.7 days with 
standard deviation (SD) 73.6 days in the presence of 8.9 mm incisor irregularity (Woodhouse 
et al. 2015). A total of 50 patients were required to detect with an unpaired t-test a 
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hypothesized 30% reduction (Schulz and Grimes 2005) in alignment time with a common SD 
across groups to yield 80% power (P=0.05). Five additional patients were recruited to account 
for possible drop-outs. 
 
Statistical methods 
Descriptive statistics were calculated, after checking for normal distribution. All biomarker data 
were Log10 transformed for normalization. Initial crude differences in baseline and outcome 
data were calculated with independent t-tests, chi-square tests or Mann-Whitney tests, where 
needed. 
The effect of obesity was investigated using univariable (crude) and multivariable 
generalized estimation equation regression models with robust standard errors to take into 
account correlation between repeated measurements for each patient through the follow-up 
period (baseline, 1 hour, 1 week, and completion of alignment), adjusted for the confounding 
effect of baseline data (sex, age, baseline-irregularity). Results are reported as 
unstandardized coefficients or Odds Ratios (ORs) for continuous and binary outcomes, 
respectively. The effect modification of obesity on the progress of tooth alignment was tested 
by introducing interaction terms, which were ultimately dropped from the model if not 
significant. Analysis of residuals was conducted to confirm the regression assumptions. As 
patients within the study had initial irregularity ranging from 4-12 mm, sensitivity analyses were 
conducted to include only those with severe (≥7 mm) or moderate (4-7 mm) baseline-
irregularity. All analyses were carried out using Stata 12.0 (Statacorp College Station, Texas, 
USA). A 2-tailed P-value of 0.05 was considered statistically significant with a 95% Confidence 
Interval (CI) for all tests. 
All primary data was coded so that the outcome assessor (HFS) and statistician (SNP) 
were blinded to subject classification. Data-coding was broken following analysis and no 
blinding breaches were identified. To examine measurement reliability and agreement, 36-
pairs of models from baseline and 1 week were selected and re-measured after 2-weeks. The 
Concordance Correlation Coefficient (CCC) (Lin 1989) and Bland-Altman method (Bland and 
Altman 1986) were used to test intra-examiner reliability and agreement. 
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Results 
Participants 
This study included 55 patients (27 male, 28 female) mean age 15.1 (SD 1.7) years and mean 
irregularity index 7.6 (SD 2.4; 95% CI 6.9-8.2) mm. Mean BMI of the cohort was 24.7 (SD 6.2) 
kg/m2. From the original 55 patients recruited, 7 were excluded at 1 week due to missed 
appointments, but all 55 were included at completion of alignment. Missingness at 1 week was 
judged as random (Appendix Table 2). The reliability and agreement of repeated 
measurements was excellent (CCC: 0.99 with 95% CI: 0.98 to 0.99; average difference 0.06 
with 95% limits of agreement: -0.68 to 0.79). Table I shows demographics and GCF 
parameters for the two cohorts at baseline. Mean BMI was 19.4 (2.2) in the normal-weight 
group and 30.2 (3.5) kg/m2 in the obese group. Apart from BMI, there were no statistically 
significant differences in demographics among groups at baseline; however, the obese group 
did have 1.2 mm more irregularity (P=0.061). In contrast, significant differences were present 
between normal-weight and obese groups for a number of GCF biomarkers at baseline (Table 
I; P<0.05) including increased GCF flow-rate, increased leptin, resistin, MPO, MMP8, TIMP1 
and RANKL, and reduced MMP9/TIMP1 levels in obese patients. 
 
Primary outcome 
The results of both crude and adjusted regression analyses indicated a small difference in 
time required to achieve tooth alignment between obese and normal-weight patients. Overall, 
obese patients needed a mean 23.0 days less than normal-weight to reach final alignment, 
but this was not statistically significant (Table II, P>0.05). 
 
Secondary outcomes 
Rates of tooth movement were significantly increased in obese patients compared to normal-
weight during the first week (P<0.001) and overall (P=0.05) (Table III), which was confirmed 
by regression modelling of the whole alignment process (Table II; P<0.001). After taking into 
account all confounders in the adjusted analysis, obese patients were associated with a 
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significantly increased rate of tooth movement compared to normal-weight (0.017 mm/day; 
95% CI: 0.008, 0.025 mm/day) (Figure 1). Additionally, a significant association was found 
between rate of tooth movement and initial irregularity (0.007 mm/day increase per mm 
irregularity). Sensitivity analyses for patients with either severe or moderate irregularity were 
consistent in direction with the main analysis (Appendix Tables 3 and 4, respectively) with an 
expected loss of power due to the division of the study sample, and a higher difference in 
alignment rate between obese and normal-weight patients in the severe irregularity group. 
uWMS increased during treatment, whilst plaque and gingival indices deteriorated 
significantly (Appendix Table 5), but there were no differences between groups for either of 
these parameters. GCF flow-rate increased during orthodontic treatment for both groups, but 
significantly more in obese patients. 
In order to further understand the biochemical basis of observed differences in rates 
of tooth movement, explorative regression analyses were undertaken (Table IV). GCF levels 
of leptin, resistin, MPO, MMP8, TIMP1, MMP9/TIMP1 and RANKL were significantly different 
between obese and normal-weight patients at baseline and during subsequent assays 
(Appendix Table 5). When a possible inter-relation between these biomarkers and rate of tooth 
movement was investigated, it was found that leptin, resistin, MPO and RANKL were 
significantly associated with the amount of tooth movement for each patient (Appendix Table 
6). Therefore, from an epidemiological basis, these biomarkers are the best candidates to 
explain the clinical performance difference between obese and normal-weight patients during 
orthodontic tooth alignment with fixed appliances. 
 
Discussion 
This prospective study followed a cohort of obese and normal-weight adolescent patients 
during the alignment phase of fixed-appliance orthodontic treatment. Obese patients needed 
less time to achieve alignment but this was not statistically significant. However, obese 
patients did show significantly increased rates of tooth movement during the whole 
observation period. This apparent discrepancy might be explained by the slightly (albeit 
statistically non-significant) increased baseline irregularity present in the obese group, or 
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between-group variation in attendance during routine appointments. Evidence exists from a 
similar experimental model that initial alignment can increase by 0.01 mm per day whilst 
overall alignment increases by 0.004 mm per day for every millimeter of initial irregularity 
(Woodhouse et al. 2015). However, significant differences were also found in the GCF 
biochemical profile between obese and normal-weight patients and to our knowledge, this 
represents the first prospective data to suggest that obese patients may respond differently to 
those with normal-weight during routine orthodontic treatment. 
Appliance variation has little or no effect on rate of orthodontic tooth movement (Scott 
et al. 2008; Woodhouse et al. 2015). Interestingly, we found that obesity does influence tooth 
movement, as obese patients had increased rates when compared to normal-weight. 
Statistical modelling of alignment rate and its change through time (see Table II) demonstrated 
that obesity and initial irregularity at each phase explained part of the variation seen in 
alignment. Given the absence of a significant interaction between obesity and time, the 
difference in alignment rate between obese and non-obese patients was consistently present 
through the alignment process and independent of confounders. 
Importantly, the groups in this investigation were not different in terms of baseline 
demographics, including plaque/gingival indices and irregularity, with BMI representing the 
only significant difference. However, a number of differences existed in baseline GCF 
parameters between groups, including GCF flow-rate and levels of several biomarkers. The 
pro-inflammatory adipokines leptin and resistin were both elevated in GCF of obese patients 
(Suresh et al. 2016), suggestive of a baseline pro-inflammatory state within the periodontium 
of these individuals. It is also consistent with the significantly increased levels of MPO, an 
established marker for inflammation in the GCF (Marcaccini et al. 2010; Navarro-Palacios et 
al. 2014). Interestingly, the levels of several biochemical mediators of tissue remodelling were 
also increased at baseline in the obese group, including MMP8, TIMP1, MMP9/TIMP1 and 
RANKL, providing evidence of an altered inflammatory biochemical profile in the GCF of obese 
patients. 
Amongst the GCF biomarkers assayed, leptin, resistin, MPO, and RANKL most 
predictably accounted for the observed differences in rate of tooth movement. The levels of 
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these biomarkers differed significantly between obese and normal-weight patients both before 
and during treatment; whilst at the same time, being significantly associated with the amount 
of tooth movement observed. Previous studies have reported that orthodontic tooth movement 
is followed by a decrease in GCF leptin (Dilsiz et al. 2010) and an increase in both MPO 
(Marcaccini et al. 2010; Navarro-Palacios et al. 2014) and RANKL (Grant et al. 2013). Resistin, 
like leptin, is upregulated in inflamed gingival tissue as compared to healthy (Suresh et al. 
2016), but the relationship between GCF resistin and orthodontic tooth movement has not 
previously been investigated. Variation in the levels of pro-inflammatory adipokines have been 
identified in the GCF of obese and normal-weight individuals with periodontal disease 
(Duzagac et al. 2016; Goncalves et al. 2015; Suresh et al. 2016; Zimmermann et al. 2013), 
but data relating to adipokines during orthodontic tooth movement is sparse (Dilsiz et al. 2010). 
The strengths of the present study include its prospective design (Papageorgiou et al. 
2015b), baseline comparability between experimental groups, absence of drop-outs at 
completion and use of measurement-blinding. Moreover, obesity was defined according to 
widely-accepted and reliable international measures. Collectively, this means that the 
respective risk for selection, attrition and detection bias is low. The study sample was based 
on a conservative a priori power calculation, and planned drop-outs did not occur. However, 
some potential limitations include the fact that height and weight measurements were only 
taken at baseline and adiposity is not necessarily a static measure. Indeed, in an adolescent 
population underlying growth might have influenced BMI during the course of the investigation, 
although with a mean observation of 158 days and mean patient age of 15.1 years, this effect 
may have been negligible. In addition, only BMI was used to classify adiposity, which can limit 
the identification of overweight and could have been reduced by adding estimates of adiposity 
(fat mass index) and fat distribution (waist-to-height ratio) (Bibiloni Mdel et al. 2013). Moreover, 
in a cohort undergoing routine orthodontic treatment with fixed appliances it is not practical to 
see each patient at exactly the same time-point for each adjustment, or identify the absolute 
first time-point that alignment is complete for every patient. For these reasons, the increased 
rates of tooth movement identified in the obese group may not have resulted in a clinically 
significant reduction in time to final alignment. In addition, whilst observed differences in rates 
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of tooth movement are tangible effects with obvious potential clinical relevance, the underlying 
biological mechanisms are likely to be complex. The measured differences in GCF biomarkers 
may be associated with the inter-relationship between obesity and tooth movement, but this 
study provides no conclusive evidence. Further investigation will be required to elucidate the 
precise role of each biomarker in mediating tooth movement. However, this investigation 
provides evidence that informs clinical practice both in orthodontics and wider-healthcare. The 
results are applicable to obese and normal-weight adolescent patients, although it should be 
remembered that adipose tissue can behave differently according to age group in other body 
systems (Palmer and Kirkland 2016). A pro-inflammatory obese state can influence 
orthodontic tooth movement, with significant associations between levels of specific 
biomarkers within the GCF of obese patients. These results highlight potential implications for 
orthodontic treatment in obese subjects and one area for future research would be a 
comparison of post-orthodontic stability. 
This prospective clinical study investigated tooth alignment in obese and normal-
weight patients undergoing fixed-appliance orthodontic treatment. Obese patients needed 
less time to achieve tooth alignment compared to normal-weight, but this was non-significant. 
After adjusting for confounders, rate of orthodontic tooth movement was significantly higher in 
obese patients compared to normal-weight. Explorative analyses indicated GCF-levels of 
leptin, resistin, MPO and RANKL were significantly different between obese and normal-
weight patients and associated with observed rates of tooth movement. 
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Figure legends 
 
Figure 1 Box plots of measured values in normal-weight and obese patients for primary 
(time to completion of alignment in days; left panel) and secondary (tooth alignment rate from 
start of treatment to completion of alignment in mm/day; right panel). Plotted boxes with 
horizontal lines indicate interquartile ranges with medians. Vertical whiskers and points 
indicate upper and lower adjacent values and outliers. 
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Table I  Demographics and GCF parameters of patients at baseline 
 
 Overall 
Normal-
weight 
Obese P value 
Demographics     
Patients (n) 55 28 27  
Male / female (n) 27/28 15/13 12/15 0.498* 
Age (years) 15.1 (1.7) 15.1 (1.6) 15.1 (1.9) 0.991# 
Caucasian – n(%) 29 (53) 17 (61) 12 (44) 0.516* 
Asian – n(%) 4 (7) 2 (7) 2 (7)  
African – n(%) 5 (9) 1 (4) 4 (15)  
Mixed – n(%) 8 (15) 3 (11) 5 (19)  
Other – n(%) 9 (16) 5 (18) 4 (15)  
BMI (kg/m2) 24.7 (6.2) 19.4 (2.2) 30.2 (3.5) <0.001# 
uWMS (mL/min) 0.61 (0.32) 0.64 (0.34) 0.58 (0.29) 0.480#  
Plaque index 0.56 (0.32) 0.57 (0.32) 0.54 (0.31) 0.745# 
Gingival index 0.74 (0.39) 0.74 (0.40) 0.73 (0.38) 0.934# 
Irregularity index (mm) 7.6 (2.4) 7.0 (2.3) 8.2 (2.4) 0.061# 
Severe irregularity – n (%) 31 (56) 13 (46) 18 (67) 0.130* 
Tooth extraction – n (%) 8 (15) 4 (14) 4 (15) 0.956* 
 
GCF biomarkers 
(Log10 transformed) 
    
GCF flow-rate (L/min) -0.29 (0.14) -0.33 (0.12) -0.25 (0.12) 0.011£ 
 
Adiponectin 6.60 (0.34) 6.55 (0.42) 6.66 (0.23) 0.237# 
Leptin‡ 13.91 (22.64) 6.40 (14.65) 19.15 (24.45) 0.031£ 
Resistin 5.61 (0.56) 5.30 (0.55) 5.92 (0.36) <0.001# 
 
MPO 5.05 (0.85) 4.44 (0.64) 5.69 (0.52) <0.001# 
CRP 2.50 (0.51) 2.47 (0.27) 2.65 (0.87) 0.827# 
MMP8 6.32 (0.64) 6.01 (0.48) 6.64 (0.64) <0.001# 
MMP9 6.23 (0.30) 6.18 (0.59) 6.27 (0.15) 0.245# 
TIMP1 5.00 (0.48) 4.72 (0.38) 5.28 (0.40) <0.001# 
MMP8/TIMP1 0.96 (0.64) 0.93 (0.62) 0.99 (0.68) 0.699# 
MMP9/TIMP1 0.54 (0.54) 0.75 (0.54) 0.32 (0.47) 0.002# 
RANKL 3.54 (0.33) 3.39 (0.25) 3.65 (0.27) <0.001£ 
 
For demographics: values are mean (SD) unless otherwise indicated. 
For GCF parameters: values are pg/mL unless otherwise indicated 
BMI, body mass index; uWMS, unstimulated whole mouth salivary flow rate; GCF, gingival crevicular fluid; MPO, 
myeloperoxidase; CRP, C-reactive protein; MMP8, matrix metalloproteinase-8; MMP9, matrix metalloproteinase-
9; TIMP1, tissue inhibitor of metalloproteinase 1; RANKL, receptor activator of nuclear factor kappa-B ligand. 
* from chi-square test. 
# from independent t-test. 
£ from Mann-Whitney test. 
Log10 transformation improved the skewness of the data, but the Shapiro-Wilk test indicated that transformed data 
were still not normally distributed. Therefore, the median (interquartile range) is presented instead of mean (SD) 
and the Mann-Whitney test is used on the transformed data instead of the unpaired t-test. 
‡ Square root transformation used instead of Log10, as several null values were included. Therefore, the median 
(interquartile range) is presented instead of mean (SD) and the Mann-Whitney test is used on the transformed data 
instead of the unpaired t-test. 
Significant results are indicated in bold 
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Table II  Regression analysis on primary (time to achieve tooth alignment in days) and secondary 
(rate of orthodontic tooth movement in mm/day) outcomes 
 
Primary outcome 
(time to completion of 
alignment) 
 Crude model Adjusted model 
Factor  b 95% CI P b 95% CI P 
BMI group Obese -14.3 -54.3,25.7 0.483 -23.0 -66.1,20.1 0.295 
 Control Ref      
        
Age Per year NT   -3.2 -15.6,9.1 0.608 
        
Gender Male NT   -6.6 -48.4,35.2 0.756 
 Female NT      
        
Ethnicity  NT   -0.2 -13.4,13.0 0.974 
        
Extraction Yes NT   -15.3 -76.0,45.5 0.623 
 No NT      
        
Baseline irregularity Per mm NT   6.9 -2.5,16.3 0.151 
        
Secondary outcome 
(alignment rate: baseline-
to completion of 
alignment) 
 Crude model Adjusted model 
Factor  b 95% CI P b 95% CI P 
BMI group Obese 0.023 0.011,0.035 <0.001 0.017 0.008,0.025 <0.001 
 Control Ref   Ref   
Time        
 1 week Ref   Ref   
 
Complete 
alignment 
-0.025 -0.036,-0.015 <0.001 -0.021 -0.032,-0.010 <0.001 
        
Age Per year  NT   0.001 -0.002,0.003 0.609 
        
Gender Male NT   0.001 -0.008,0.011 0.768 
 Female NT   Ref   
        
Ethnicity  NT   -0.001 -0.003,0.002 0.643 
        
Irregularity 
at each phase start 
Per mm  NT   0.007 0.005,0.009 <0.001 
        
Extraction Yes NT   -0.004 -0.014,0.006 0.415 
 No NT   Ref   
 
b, unstandardized regression coefficient; CI confidence interval; BMI, body mass index; Ref, reference; NT, not 
tested. *Interaction of obesity with time found to be non-significant (P=0.112) and was dropped from the model. 
Significant results are indicated in bold 
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Table III Rate of tooth movement (mm/day) during the study period 
 
Outcome 
Overall 
(n=55) 
Normal-weight 
(n=28) 
Obese 
(n=27) 
P value 
Time to completion of alignment (d) – mean 
(SD) 
158.7 (75.3) 165.8 (72.5) 151.4 (78.7) 0.486 
Tooth alignment rate: baseline to 
completion of alignment (mm/d) – mean 
(SD) 
0.057 (0.029) 0.050 (0.025) 0.065 (0.031) 0.050* 
Tooth alignment rate: baseline to week 1 
(mm/d) – mean (SD)† 
0.081 (0.031) 0.065 (0.025) 0.097 (0.028) <0.001* 
Tooth alignment rate: week 1 to completion 
of alignment (mm/d) – mean (SD) † 
0.056 (0.031) 0.049 (0.027) 0.063 (0.033) 0.119* 
 
d, days; SD, standard deviation; CI, confidence interval. 
*from independent t-test. 
†Due to 7 patient drop-outs at 1 week, 48/55 patients (24 obese and 24 control patients) are included in 
these two measurements. The measurement of time to completion of alignment and alignment rate: baseline 
to completion of alignment pertain to the whole sample of 55 patients. 
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Table IV Summary of exploratory analyses on the secondary outcome: GCF biomarker levels 
 
  
Different in obese 
and control at 
baseline 
(Table I) 
Different in obese and 
control during treatment 
(Appendix Table 5 ) 
Associated with 
alignment rate 
(Appendix Table 6 ) 
Clinical 
indices 
    
 Plaque index No No - 
 Gingival index No No - 
 uWMS No No - 
 GCF volume Yes Yes No 
GCF 
biomarkers 
    
 Adiponectin No No - 
 Leptin Yes Yes Yes 
 Resistin Yes Yes Yes 
 MPO Yes Yes Yes 
 CRP No No - 
 MMP8 Yes Yes No 
 MMP9 No No - 
 TIMP1 Yes Yes No 
 MMP8/TIMP1 No No - 
 MMP9/TIMP1 Yes Yes No 
 RANKL Yes Yes Yes 
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Appendix Figure 1 Patient flow through the investigation 
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Appendix Table 1 Limits of detection and coefficients of variation for GCF biomarker luminex 
analysis 
 
 
Biomarker * 
Lower limit  
of detection 
(pg/mL) 
Upper limit  
of detection 
(pg/mL) 
Coefficient of 
variation 
(%) 
Adiponectin 193.74 432390.10 2.4 
Leptin 55.15 111251.22 3.0 
Resistin 4.83 9709.28 1.8 
MMP8 25.45 53522.68 2.3 
MMP9 20.03 41870.79 2.8 
TIMP1 7.91 17479.14 2.1 
MPO 16.31 34627.04 2.8 
CRP 17.29 38785.30 2.4 
RANKL 5.14 10509.81 2.3 
 
* all manufactured by R+D Systems 
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Appendix Table 2 Demographics of the initially-recruited sample at baseline and the sample 
after patient drop-outs at 1 week 
 
 Overall Control Obese P value 
Recruited sample (data for 
baseline, completion of alignment) 
    
Patients 55 28 27  
Male - n (%) 27 (49%) 15 (54%) 12 (44%) 0.498* 
Age - mean (SD) 15.1 (1.7) 15.1 (1.6) 15.1 (1.9) 0.991# 
Irregularity - mean (SD) 7.6 (2.4) 7.0 (2.3) 8.2 (2.4) 0.061# 
BMI - mean (SD) 24.7 (6.2) 19.4 (2.2) 30.2 (3.5) <0.001# 
     
Sample with drop-outs (data for 1 
week) 
    
Patients 48 24 24  
Male - n (%) 24 (50%) 13 (54%) 11 (46%) 0.564* 
Age - mean (SD) 15.3 (1.7) 15.2 (1.6) 15.3 (1.8) 0.737# 
Irregularity - mean (SD) 7.7 (2.4) 7.2 (2.3) 8.2 (2.5) 0.156# 
BMI - mean (SD) 24.7 (6.2) 19.3 (2.2) 30.2 (3.6) <0.001# 
 
SD, standard deviation; BMI, body mass index. 
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Appendix Table 3 Sensitivity analysis: regression analysis on the primary (time to completion of 
alignment in days) and secondary outcome (rate of tooth movement in mm/day) for the category of patients 
with severe initial crowding (≥7 mm; n=31) 
 
    Crude model Adjusted model 
  Factor  b 95% CI P b 95% CI P 
S
e
n
s
it
iv
it
y
 a
n
a
ly
s
is
: 
in
it
ia
l 
c
ro
w
d
in
g
 ≥
7
 m
m
 (
n
=
3
1
) 
P
ri
m
a
ry
 o
u
tc
o
m
e
: 
ti
m
e
 t
o
 a
lig
n
m
e
n
t BMI group Obese -16.0 -67.9,35.9 0.545 -16.1 -77.6,45.3 0.607 
 Control Ref   Ref   
        
Age Per year NT   -3.8 -18.9,11.2 0.617 
        
Gender Male    11.6 -46.4,69.6 0.695 
 Female NT   Ref   
        
Ethnicity  NT   -5.9 -24.0,12.3 0.527 
        
Irregularity at baseline Per mm NT   17.3 -2.4,37.0 0.085 
        
Extraction Yes    -11.2 -74.8,52.5 0.731 
 No NT   Ref   
         
 Factor  b 95% CI P b 95% CI P 
S
e
c
o
n
d
a
ry
 o
u
tc
o
m
e
: 
a
lig
n
m
e
n
t 
ra
te
 
BMI group Obese 0.022 0.009,0.035 0.001 0.021 0.008,0.033 0.002 
 Control Ref   Ref   
Time point*        
1 week  Ref   Ref   
Completion of 
alignment 
 -0.033 -0.048,-0.018 <0.001 -0.029 -0.046,-0.0129 <0.001 
        
Age Per year NT   0.001 -0.003,0.005 0.614 
        
Gender Male    0.003 -0.009,0.015 0.625 
 Female Ref   Ref   
        
Ethnicity  NT   -0.000 -0.005,0.004 0.828 
        
Irregularity at each 
phase start 
Per mm NT   0.005 0.000,0.010 0.037 
        
Extraction Yes    -0.001 -0.014,0.012 0.910 
 No Ref   Ref   
 
 
b, unstandardized regression coefficient; CI, confidence interval; Ref, reference. 
*Interaction of obesity with time found to be non-significant (P=0.171) and was dropped from the model. 
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Appendix Table 4 Sensitivity analysis: regression analysis on the primary (time to completion of 
alignment in days) and secondary outcome (rate of tooth movement in mm/day) for the category of patients 
with moderate initial crowding (<7mm; n=24). 
 
 
    Crude model Adjusted model 
  Factor  b 95% CI P b 95% CI P 
S
e
n
s
it
iv
it
y
 a
n
a
ly
s
is
: 
in
it
ia
l 
c
ro
w
d
in
g
 <
7
 m
m
 (
n
=
2
4
) 
P
ri
m
a
ry
 o
u
tc
o
m
e
: 
ti
m
e
 t
o
 a
lig
n
m
e
n
t BMI group Obese -18.04 -85.68,49.59 0.601 2.7 -78.2,83.6 0.948 
 Control Ref   Ref   
        
Age Per year NT   8.1 -17.8,34.0 0.540 
        
Gender Male    -40.2 -117.1,36.7 0.305 
 Female NT   Ref   
        
Ethnicity  NT   8.2 -14.3,30.8 0.474 
        
Irregularity at baseline Per mm NT   7.2 -34.1,48.4 0.734 
        
Extraction Yes    -32.7 -227.6,162.2 0.742 
 No NT   Ref   
         
S
e
c
o
n
d
a
ry
 o
u
tc
o
m
e
: 
a
lig
n
m
e
n
t 
ra
te
 
  b 95% CI P b 95% CI P 
BMI group Obese 0.013 -0.002,0.028 0.100 0.013 0.001,0.025 0.039 
 Control Ref   Ref   
Time point*        
1 week  Ref   Ref   
Completion of 
alignment 
 -0.015 -0.028,-0.001 0.030 -0.012 -0.026,0.003 0.117 
        
Age Per year NT   -0.001 -0.005,0.002 0.484 
        
Gender Male    0.003 -0.009,0.014 0.657 
 Female NT   Ref   
        
Ethnicity  NT   -0.001 -0.005,0.002 0.491 
        
Irregularity at each 
phase start 
Per mm NT   0.007 -0.001,0.015 0.104 
        
Extraction Yes    -0.005 -0.020,0.009 0.477 
 No NT   Ref   
 
b, unstandardized regression coefficient; CI, confidence interval; Ref, reference. 
*Interaction of obesity with time found to be non-significant (P=0.171) and was dropped from the model. 
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Appendix Table 5 Results of regression models assessing the effect of obesity and time-
variation during orthodontic treatment on the levels of clinical indices and GCF biomarkers. 
Explorative interactions between obesity and time were tested in each case, but were dropped from 
the model if they were not statistically significant. 
 
Biomarker 
transformation 
Factor 
  b 95% CI P 
uWMS Obese Time -0.03 -0.13,0.08 0.594 
Log10 transformed Time Baseline Ref     
   1 hour 0.19 0.15,0.25 <0.001 
   1 week 0.18 0.11,0.26 <0.001 
   
Completion 
of alignment 0.18 0.12,0.24 <0.001 
 Interaction    0.502 
       
Plaque index Obese  0.03 -0.05,0.12 0.460 
Log10 transformed Time Baseline Ref   
  1 hour  -   
  1 week 0.16 0.07,0.26 0.001 
  
Completion 
of alignment 0.34 0.27,0.41 
<0.001 
 Interaction    0.353 
       
Gingival index Obese  0.04 -0.05,0.12 0.391 
Log10 transformed Time Baseline Ref   
  1 hour  -   
  1 week 0.14 0.06,0.21 0.001 
  
Completion 
of alignment 0.30 0.24,0.36 <0.001 
 Interaction    0.206 
      
GCF flow-rate Obese  0.08 0.04,0.13 <0.001 
Log10 transformed Time Baseline Ref     
   1 hour 0.10 0.05,0.15 <0.001 
   1 week 0.10 0.06,0.14 <0.001 
   
Completion 
of alignment 0.09 0.04,0.13 <0.001 
  Interaction       0.282 
      
Adiponectin Obese  0.08 -0.12,0.28 0.417 
Log10 transformed Time Baseline Ref     
  1 hour 0.15 0.04,0.26 0.010 
  1 week 0.23 0.10,0.36 <0.001 
  
Completion 
of alignment 0.15 0.01,0.28 0.031 
 Interaction   -0.07 -0.13,-0.01 0.027 
           
Leptin Obese  6.41 1.71,11.10 0.007 
Square-root transformed Time Baseline Ref     
   1 hour -2.44 -5.18,0.29 0.080 
   1 week -1.21 -1.85,4.27 0.439 
   
Completion 
of alignment -4.44 -8.50,-0.38 0.032 
  Interaction       0.556 
           
Resistin Obese  0.60 0.44,0.76 <0.001 
Log10 transformed Time Baseline Ref     
   1 hour 0.13 -0.04,0.30 0.124 
   1 week 0.03 -0.16,0.21 0.757 
 27 
   
Completion 
of alignment -0.05 -0.18,0.09 0.519 
 Interaction       0.975 
           
MPO Obese  1.36 1.11,1.62 <0.001 
Log10 transformed Time Baseline Ref     
   1 hour 0.36 0.13,0.59 0.003 
   1 week 0.56 0.39,0.74 <0.001 
   
Completion 
of alignment 0.69 0.52,0.87 <0.001 
 Interaction      0.994 
           
CRP Obese  -0.02 -0.24,0.20 0.860 
Log10 transformed Time Baseline  Ref     
   1 hour 0.10 -0.04,0.23 0.149 
   1 week 0.27 0.09,0.46 0.004 
   
Completion 
of alignment 0.26 0.07,0.44 0.006 
 Interaction      0.192 
           
MMP8 Obese  0.62 0.32,0.93 <0.001 
Log10 transformed Time Baseline  Ref     
   1 hour 0.16 0.05,0.28 0.007 
   1 week 0.12 0.01,0.23 0.037 
   
Completion 
of alignment 0.05 -0.07,0.17 0.446 
 Interaction      0.995 
           
MMP9 Obese  0.06 -0.02,0.15 0.149 
Log10 transformed Time Baseline  Ref     
   1 hour 0.38 0.28,0.49 <0.001 
   1 week 0.35 0.25,0.44 <0.001 
   
Completion 
of alignment 0.08 -0.03,0.19 
0.181 
 Interaction      0.388 
           
TIMP1 Obese   0.61 0.38,0.84 <0.001 
Log10 transformed Time Baseline  Ref     
   1 hour -0.04 -0.20,0.13 0.668 
   1 week 0.25 0.07,0.42 0.005 
   
Completion 
of alignment 0.42 0.23,0.60 <0.001 
 Interaction   -0.08 -0.15,-0.00 0.040 
           
MMP8/TIMP1 Obese   0.20 -0.14,0.54 0.254 
Log10 transformed Time Baseline  Ref     
   1 hour 0.24 0.03,0.45 0.027 
   1 week -0.05 -0.22,0.13 0.600 
   
Completion 
of alignment -0.25 -0.42,-0.08 0.003 
 Interaction       0.166 
           
MMP9/TIMP1 Obese   -0.34 -0.57,-0.11 0.004 
Log10 transformed           
 Time Baseline Ref     
   1 hour 0.46 0.33,0.59 <0.001 
   1 week 0.18 0.02,0.34 0.024 
   
Completion 
of alignment -0.23 -0.35,-0.10 
<0.001 
 28 
 Interaction       0.239 
           
RANKL Obese   0.38 0.28,0.48 <0.001 
Log10 transformed Time Baseline  Ref     
   1 hour 0.01 -0.06,0.09 0.733 
   1 week 0.03 -0.06,0.12 0.532 
   
Completion 
of alignment 0.37 0.27,0.47 <0.001 
 Interaction       0.089 
 
b, unstandardized regression coefficient; CI, confidence interval; Ref, reference; GCF, gingival 
crevicular fluid; MPO, myeloperoxidase; CRP, C reactive protein; MMP8, matrix metalloproteinase-8; 
MMP9, matrix metalloproteinase-9; TIMP1, tissue inhibitor of metalloproteinase 1; RANKL, receptor 
activator of nuclear factor kappa-B ligand. 
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Appendix Table 6 Results of regression models assessing the association of time-variation 
during orthodontic treatment, baseline irregularity, and biomarker levels with tooth alignment rate in 
mm/day 
 
Biomarker 
transformation 
Factor b 95% CI P 
Leptin Time -0.017 -0.029,-0.005 0.005 
Square-root transformed Baseline irregularity 0.007 0.005,0.010 <0.001 
 Leptin 0.001 0.000,0.001 0.006 
     
Resistin Time -0.020 -0.030,-0.010 <0.001 
Log10 transformed Baseline irregularity 0.007 0.005,0.010 <0.001 
 Resistin 0.013 0.006,0.020 0.001 
     
MPO Time -0.022 -0.032,-0.012 <0.001 
Log10 transformed Baseline irregularity 0.007 0.005,0.009 <0.001 
 MPO 0.010 0.004,0.014 <0.001 
     
MMP8 Time -0.021 -0.031,-0.010 <0.001 
Log10 transformed Baseline irregularity 0.007 0.005,0.010 <0.001 
 MMP8 0.003 -0.004,0.010 0.415 
     
TIMP1 Time -0.022 -0.032,-0.011 <0.001 
Log10 transformed Baseline irregularity 0.007 0.005,0.010 <0.001 
 TIMP1 0.004 -0.004,0.012 0.335 
     
MMP9/TIMP1 Time -0.022 -0.033,-0.010 <0.001 
Log10 transformed Baseline irregularity 0.007 0.005,0.009 <0.001 
 MMP9/TIMP1 -0.003 -0.012,0.007 0.592 
     
RANKL Time -0.025 -0.035,-0.014 <0.001 
Log10 transformed Baseline irregularity 0.007 0.005,0.010 <0.001 
 RANKL 0.011 0.000,0.022 0.040 
 
MPO, myeloperoxidase; MMP8, matrix metalloproteinase-8; TIMP1, tissue inhibitor of 
metalloproteinase 1; RANKL, receptor activator of nuclear factor kappa-B ligand. 
 
 
 
 
